Moderna has asked the FDA for emergency use authorisation for a fourth dose of its mRNA COVID-19 ... though - Pfizer is seeking a green light for second booster dose of Comirnaty for people ...

The rivalry between Moderna and Pfizer ... opportunity for booster shots targeting new variants like Omicron as COVID-19 becomes endemic. It's not the first time Pfizer and BioNTech have been ...

Please note that in Japan, ARCT-154 first received approval in November 2023 as the first sa-mRNA COVID-19 vaccine for initial vaccination and booster ... Pfizer/BioNTech’s Comirnaty and Moderna ...

Update (September 2): The CDC greenlighted the use of the Moderna and Pfizer Omicron boosters ... a fourth dose of the original COVID-19 vaccines. Speaking about the choice for healthy people between ...

researchers recommended that people who received it get a second booster dose with an mRNA vaccine such as Moderna and Pfizer. According to the published results, there were 129 coronavirus ...

When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and ...

While sales of its COVID-19 vaccine continue to decline ... Sales of RSV vaccines marketed by Moderna’s rivals, Pfizer PFE and GSK plc GSK, also declined in the first quarter.

As you know, we have a bunch of applications for those booster shots," FDA Commissioner ... for the following winter. Updates to Moderna and Pfizer's COVID shots for the new strain were approved ...

New COVID booster vaccines ... include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID ...

COVID-19 vaccine sales have declined, but other vaccines are still growth drivers for several companies. Top vaccine stocks for investors to consider include Pfizer and Moderna. Other vaccine ...

01. Confusion over the Food and Drug Administration’s delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend when the agency’s commissioner, Marty Makary ...

A protein-based booster vaccine made by Novavax, which works differently to the Pfizer and Moderna jabs, is also available. Moderna hopes to launch a combined flu and Covid vaccine later in 2025 ...